FRANKFURT, March 9 (Reuters) - Roche's shares dropped more than 7% at one stage on Monday, their biggest decline in nearly a ...

Roche's shares dropped more than 5% on Monday as the ​Swiss drugmaker failed to show that its promising breast cancer drug ...

FRANKFURT, March 9 (Reuters) - Shares in Roche dropped more than 5% on Monday as the Swiss drugmaker failed to show that its ...

FRANKFURT, March 9 (Reuters) - Roche's shares dropped more than 5% on Monday as the Swiss drugmaker failed to show that its ...

The signs and symptoms of throat cancer have been explained, with many unaware of its link to oral sex. Actor Michael Douglas went public with his cancer diagnosis back in 2010, but only revealed that ...

Bishnoi Dental Care has conducted 1,000+ outreach camps in Rajasthan, screening 40,000 rural patients and improving dental ...

AstraZeneca has also filed an oral SERD, camizestrant, targeting use of the drug in patients with advanced HR-positive breast ...

A phase 3 trial of Roche’s giredestrant in first-line breast cancer patients has missed its primary endpoint, tarnishing the record of a drug that hit the mark in adjuvant and second-line settings.

A guide to Medicare coverage for breast cancer diagnosis and treatment, including cost differences between Original Medicare ...

The biopharmaceutical company on Monday said its proposed drug, oral mezigdomide, used in combination with an existing treatment, carfilzomib and dexamethasone, demonstrated "statistically significant ...

By Sneha S K March 9 (Reuters) - Bristol Myers Squibb on Monday said its experimental drug for a rare form of blood cancer ...

Roquefort Therapeutics is acquiring exclusive worldwide rights to a clinical-stage tumour inhibitor for £32m in an all-paper deal and raising £8.5 million.